Global Digital Biomarker Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032
Description
Market Overview
According to DIResearch＇s in-depth investigation and research, the global Digital Biomarker market size will reach 1,989.95 Million USD in 2025 and is projected to reach 136,146.24 Million USD by 2032, with a CAGR of 82.88% (2025-2032). Notably, the China Digital Biomarker market has changed rapidly in the past few years. By 2025, China＇s market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
A digital biomarker refers to quantifiable and measurable physiological, behavioral, or biological data collected through digital devices and technologies, such as smartphones, wearables, or sensors. These data points are used to monitor and track health-related information, disease progression, treatment outcomes, and overall well-being. Digital biomarkers have the potential to provide continuous, real-time data, allowing for more comprehensive insights compared to traditional sporadic clinical assessments. They can include parameters like heart rate variability, activity levels, sleep patterns, cognitive performance, and even voice or speech characteristics. The integration of digital biomarkers into healthcare and medical research holds promise for early disease detection, personalized treatments, remote patient monitoring, and advancing our understanding of various health conditions.
The major global suppliers of Digital Biomarker include Philips, Johnson & Johnson, Pfizer, GE Healthcare, Novartis, Sanofi, GlaxoSmithKline, Bayer, Merck, Apple, Abbott Laboratories, Asahi Kasei, Biogen, Koneksa Health, Roche, Huma Therapeutics, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Digital Biomarker. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Digital Biomarker market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Digital Biomarker market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Digital Biomarker industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Digital Biomarker Include:
Philips
Johnson & Johnson
Pfizer
GE Healthcare
Novartis
Sanofi
GlaxoSmithKline
Bayer
Merck
Apple
Abbott Laboratories
Asahi Kasei
Biogen
Koneksa Health
Roche
Huma Therapeutics
Digital Biomarker Product Segment Include:
Passive Digital Biomarker
Active Digital Biomarker
Digital Biomarker Product Application Include:
Clinical Disease
Daily Health
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Digital Biomarker Industry PESTEL Analysis
Chapter 3: Global Digital Biomarker Industry Porter's Five Forces Analysis
Chapter 4: Global Digital Biomarker Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global Digital Biomarker Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global Digital Biomarker Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, Digital Biomarker Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
According to DIResearch＇s in-depth investigation and research, the global Digital Biomarker market size will reach 1,989.95 Million USD in 2025 and is projected to reach 136,146.24 Million USD by 2032, with a CAGR of 82.88% (2025-2032). Notably, the China Digital Biomarker market has changed rapidly in the past few years. By 2025, China＇s market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
A digital biomarker refers to quantifiable and measurable physiological, behavioral, or biological data collected through digital devices and technologies, such as smartphones, wearables, or sensors. These data points are used to monitor and track health-related information, disease progression, treatment outcomes, and overall well-being. Digital biomarkers have the potential to provide continuous, real-time data, allowing for more comprehensive insights compared to traditional sporadic clinical assessments. They can include parameters like heart rate variability, activity levels, sleep patterns, cognitive performance, and even voice or speech characteristics. The integration of digital biomarkers into healthcare and medical research holds promise for early disease detection, personalized treatments, remote patient monitoring, and advancing our understanding of various health conditions.
The major global suppliers of Digital Biomarker include Philips, Johnson & Johnson, Pfizer, GE Healthcare, Novartis, Sanofi, GlaxoSmithKline, Bayer, Merck, Apple, Abbott Laboratories, Asahi Kasei, Biogen, Koneksa Health, Roche, Huma Therapeutics, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Digital Biomarker. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Digital Biomarker market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Digital Biomarker market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Digital Biomarker industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Digital Biomarker Include:
Philips
Johnson & Johnson
Pfizer
GE Healthcare
Novartis
Sanofi
GlaxoSmithKline
Bayer
Merck
Apple
Abbott Laboratories
Asahi Kasei
Biogen
Koneksa Health
Roche
Huma Therapeutics
Digital Biomarker Product Segment Include:
Passive Digital Biomarker
Active Digital Biomarker
Digital Biomarker Product Application Include:
Clinical Disease
Daily Health
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Digital Biomarker Industry PESTEL Analysis
Chapter 3: Global Digital Biomarker Industry Porter's Five Forces Analysis
Chapter 4: Global Digital Biomarker Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global Digital Biomarker Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global Digital Biomarker Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, Digital Biomarker Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
Table of Contents
165 Pages
- 1 Digital Biomarker Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Digital Biomarker Product by Type
- 1.2.1 Passive Digital Biomarker
- 1.2.2 Active Digital Biomarker
- 1.3 Digital Biomarker Product by Application
- 1.3.1 Clinical Disease
- 1.3.2 Daily Health
- 1.4 Global Digital Biomarker Market Size Analysis (2020-2032)
- 1.5 Digital Biomarker Market Development Status and Trends
- 1.5.1 Digital Biomarker Industry Development Status Analysis
- 1.5.2 Digital Biomarker Industry Development Trends Analysis
- 2 Digital Biomarker Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Digital Biomarker Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Digital Biomarker Market Analysis by Country
- 4.1 Global Digital Biomarker Market Size Analysis by Country: 2024 VS 2025 VS 2032
- 4.1.1 Global Digital Biomarker Revenue Analysis by Country (2020-2025)
- 4.1.2 Global Digital Biomarker Revenue Forecast Analysis by Country (2026-2032)
- 4.2 United States Digital Biomarker Market Revenue and Growth Rate (2020-2032)
- 4.3 Germany Digital Biomarker Market Revenue and Growth Rate (2020-2032)
- 4.4 Japan Digital Biomarker Market Revenue and Growth Rate (2020-2032)
- 4.5 China Digital Biomarker Market Revenue and Growth Rate (2020-2032)
- 4.6 France Digital Biomarker Market Revenue and Growth Rate (2020-2032)
- 4.7 U.K. Digital Biomarker Market Revenue and Growth Rate (2020-2032)
- 4.8 South Korea Digital Biomarker Market Revenue and Growth Rate (2020-2032)
- 4.9 Canada Digital Biomarker Market Revenue and Growth Rate (2020-2032)
- 4.10 Italy Digital Biomarker Market Revenue and Growth Rate (2020-2032)
- 4.11 Russia Digital Biomarker Market Revenue and Growth Rate (2020-2032)
- 4.12 Mexico Digital Biomarker Market Revenue and Growth Rate (2020-2032)
- 4.13 Brazil Digital Biomarker Market Revenue and Growth Rate (2020-2032)
- 4.14 India Digital Biomarker Market Revenue and Growth Rate (2020-2032)
- 4.15 Vietnam Digital Biomarker Market Revenue and Growth Rate (2020-2032)
- 4.16 Thailand Digital Biomarker Market Revenue and Growth Rate (2020-2032)
- 4.17 South Africa Digital Biomarker Market Revenue and Growth Rate (2020-2032)
- 5 Competition by Suppliers
- 5.1 Global Digital Biomarker Market Revenue by Key Suppliers (2021-2025)
- 5.2 Global Digital Biomarker Competitive Landscape Analysis and Market Dynamic
- 5.2.1 Digital Biomarker Competitive Landscape Analysis
- 5.2.2 Global Key Suppliers Headquarter and Key Area Sales
- 5.2.3 Market Dynamic
- 6 Digital Biomarker Market Analysis by Type
- 6.1 Global Digital Biomarker Market Size Analysis by Type: 2024 VS 2025 VS 2032
- 6.2 Global Digital Biomarker Revenue and Forecast Analysis by Type (2020-2032)
- 7 Key Companies Analysis
- 7.1 Philips
- 7.1.1 Philips Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.1.2 Philips Digital Biomarker Product Portfolio
- 7.1.3 Philips Digital Biomarker Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.2 Johnson & Johnson
- 7.2.1 Johnson & Johnson Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.2.2 Johnson & Johnson Digital Biomarker Product Portfolio
- 7.2.3 Johnson & Johnson Digital Biomarker Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.3 Pfizer
- 7.3.1 Pfizer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.3.2 Pfizer Digital Biomarker Product Portfolio
- 7.3.3 Pfizer Digital Biomarker Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.4 GE Healthcare
- 7.4.1 GE Healthcare Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.4.2 GE Healthcare Digital Biomarker Product Portfolio
- 7.4.3 GE Healthcare Digital Biomarker Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.5 Novartis
- 7.5.1 Novartis Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.5.2 Novartis Digital Biomarker Product Portfolio
- 7.5.3 Novartis Digital Biomarker Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.6 Sanofi
- 7.6.1 Sanofi Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.6.2 Sanofi Digital Biomarker Product Portfolio
- 7.6.3 Sanofi Digital Biomarker Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.7 GlaxoSmithKline
- 7.7.1 GlaxoSmithKline Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.7.2 GlaxoSmithKline Digital Biomarker Product Portfolio
- 7.7.3 GlaxoSmithKline Digital Biomarker Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.8 Bayer
- 7.8.1 Bayer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.8.2 Bayer Digital Biomarker Product Portfolio
- 7.8.3 Bayer Digital Biomarker Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.9 Merck
- 7.9.1 Merck Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.9.2 Merck Digital Biomarker Product Portfolio
- 7.9.3 Merck Digital Biomarker Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.10 Apple
- 7.10.1 Apple Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.10.2 Apple Digital Biomarker Product Portfolio
- 7.10.3 Apple Digital Biomarker Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.11 Abbott Laboratories
- 7.11.1 Abbott Laboratories Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.11.2 Abbott Laboratories Digital Biomarker Product Portfolio
- 7.11.3 Abbott Laboratories Digital Biomarker Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.12 Asahi Kasei
- 7.12.1 Asahi Kasei Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.12.2 Asahi Kasei Digital Biomarker Product Portfolio
- 7.12.3 Asahi Kasei Digital Biomarker Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.13 Biogen
- 7.13.1 Biogen Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.13.2 Biogen Digital Biomarker Product Portfolio
- 7.13.3 Biogen Digital Biomarker Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.14 Koneksa Health
- 7.14.1 Koneksa Health Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.14.2 Koneksa Health Digital Biomarker Product Portfolio
- 7.14.3 Koneksa Health Digital Biomarker Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.15 Roche
- 7.15.1 Roche Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.15.2 Roche Digital Biomarker Product Portfolio
- 7.15.3 Roche Digital Biomarker Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.16 Huma Therapeutics
- 7.16.1 Huma Therapeutics Basic Company Profile
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
